Department of Chemistry , University of Rochester , 120 Trustee Road , Rochester , New York 14627 , United States.
J Am Chem Soc. 2019 Jun 12;141(23):9145-9150. doi: 10.1021/jacs.9b02700. Epub 2019 May 29.
We report the development of engineered myoglobin biocatalysts for executing asymmetric intramolecular cyclopropanations resulting in cyclopropane-fused γ-lactones, which are key motifs found in many bioactive molecules. Using this strategy, a broad range of allyl diazoacetate substrates were efficiently cyclized in high yields with up to 99% enantiomeric excess. Upon remodeling of the active site via protein engineering, myoglobin variants with stereodivergent selectivity were also obtained. In combination with whole-cell transformations, these biocatalysts enabled the gram-scale assembly of a key intermediate useful for the synthesis of the insecticide permethrin and other natural products. The enzymatically produced cyclopropyl-γ-lactones can be further elaborated to furnish a variety of enantiopure trisubstituted cyclopropanes. This work introduces a first example of biocatalytic intramolecular cyclopropanation and provides an attractive strategy for the stereodivergent preparation of fused cyclopropyl-γ-lactones of high value for medicinal chemistry and the synthesis of natural products.
我们报告了工程化肌红蛋白生物催化剂的开发,用于执行不对称分子内环丙烷化反应,生成环丙烷稠合的γ-内酰胺,这是许多生物活性分子中存在的关键结构。使用这种策略,广泛的烯丙基重氮乙酸酯底物可以以高达 99%的对映体过量高效地环化,收率很高。通过蛋白质工程对活性位点进行改造,还获得了具有立体选择性的肌红蛋白变体。结合全细胞转化,这些生物催化剂能够实现克级规模合成用于合成杀虫剂氯菊酯和其他天然产物的关键中间体。通过酶法制备的环丙基-γ-内酰胺可以进一步修饰,得到各种手性纯的三取代环丙烷。这项工作介绍了首例生物催化分子内环丙烷化反应的例子,并为立体发散性制备具有医学化学和天然产物合成价值的稠合环丙基-γ-内酰胺提供了一种有吸引力的策略。